Title : Fats of life, the skinny on statins and beyond !
Abstract:
With Cardiovascular disease still the primary killer of adults globally, tackling lipid disorders has proven extremely useful from the statins experience since the early nineties. However, goals are not met regarding the lipid parameters for the vast majority of the world adult populations, for both those who sustained ASCVD, and those heading to a similar outcome.
Many, didn’t achieve goals with the maximum tolerated statins dose. Others couldn’t tolerate statins. Many others experienced the nocebo effect creating a barrier to reach goals using the least expensive tools.
I try in this presentation highlighting some clinical pearls from my experience as a lipid clinic founder and a practicing lipidologist in a major tertiary academic center in using statins, and overcoming common barriers, including debunking common myths, and unfounded fears.
I also discuss alternatives, newer modalities, both approved, and those novel tools in the pipeline. Elaborating on their mechanisms, using them with what we have to create the ideal CV outcome to our patients.
I also address in this presentation a common mistake unfortunately done by patients and some providers in stopping Lipid lowering agents suddenly. I will elaborate on the Acute Phase transition of cholesterol and cholesterol crystals and what experts are warning of especially in light of new imaging techniques focusing on the plaques composition and structure.
